Physician profile
Robert L Dean
NPI 1255389532
$3,958.84
in general payments reported to CMS, 2019-2025
21 companies · $857 in 2025
The $857 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $192 · 2021: $305 · 2022: $532 · 2023: $1,070 · 2024: $743 · 2025: $857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,308 · Travel and Lodging: $328 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,307.58 |
| Travel and Lodging | $327.86 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,789.70 | 2019-2025 | |
| Stryker Corporation | $408.27 | 2019-2023 | Latera |
| Glaxosmithkline, LLC. | $381.91 | 2021-2025 | Nucala |
| Genzyme Corporation | $338.53 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $200.42 | 2021-2025 | Dupixent |
| Optinose US, INC. | $187.13 | 2021-2022 | |
| Medtronic, INC. | $108.96 | 2021-2024 | Propel, Nuvent, Sinuva |
| Medtronic USA, INC. | $108.26 | 2020 | |
| Amgen INC. | $66.00 | 2022-2025 | |
| Carestream Dental, LLC | $62.44 | 2019 | |
| Kaleo, INC. | $57.04 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $50.36 | 2023-2025 | Keytruda |
| Abbott Laboratories | $48.12 | 2023 | Mitraclip |
| Kls-Martin L.P. | $36.98 | 2023-2024 | |
| Davol INC. | $33.57 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $20.68 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Cochlear Americas | $18.50 | 2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Smith+Nephew, INC. | $16.93 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.82 | 2022 | |
| Itamar Medical INC | $12.22 | 2024 | Watchpatone |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.